Point-of-Care Testing (POCT) Devices

Point-of-Care Testing Devices LR 3003/50 LSR Injection Molding with Arburg Allrounder H 600T

In the high-stakes world of medical device engineering, particularly for Point-of-Care Testing (POCT) Devices, the margin for error is non-existent. These devices—ranging from glucose meters to complex microfluidic diagnostic cartridges—are shrinking in size while their functional complexity skyrockets. This paradigm shift places immense pressure on manufacturing processes. Engineers are tasked with creating components that feature intricate micro-scale channels, optically perfect windows, and flexible, biocompatible seals, all within a single, cost-effective part. The central challenge is not just achieving these features once, but replicating them millions of times with near-perfect Cpk values. This is where conventional molding approaches falter, plagued by issues of material degradation, dimensional instability, and contamination. The very properties that make a material ideal for the application can make it a nightmare to process. This technical brief dissects a specific, highly-optimized manufacturing cell at MechanoFab, engineered to conquer these challenges: the precise marriage of a specialized liquid silicone rubber with a state-of-the-art injection molding platform.

The core of this solution lies in a deep understanding of the material-process interaction. We are targeting components that often serve multiple functions: a structural housing, a flexible sealing membrane, and an optical pathway for a sensor. For this, we utilize Wacker ELASTOSIL LR 3003/50, a platinum-cured liquid silicone rubber (LSR). Its 50 Shore A hardness provides the ideal balance of flexibility for sealing and structural integrity for handling. More importantly, its exceptional purity and biocompatibility are prerequisites for any material in direct or indirect contact with patient samples. However, its extremely low viscosity, while excellent for replicating fine microfluidic details, presents a significant processing hurdle. It will exploit any microscopic imperfection in a mold's parting line, resulting in flash—thin, unwanted films of material that can obscure optical paths, block micro-channels, or compromise seal integrity. For a POCT device, flash isn't a cosmetic defect; it's a functional failure that renders the device useless. Eliminating this risk at the source, within the mold, is the only viable path to high-volume, high-yield production.

Uncompromising Compliance: Engineering for ISO 13485, FDA 21 CFR 820, and CE IVDR

Manufacturing for the medical device sector is governed by a stringent regulatory framework. It's not enough to simply produce a part that meets the drawing specifications; the entire process must be validated, documented, and controlled under a robust Quality Management System (QMS). Our dedicated manufacturing cell is architected from the ground up to exceed the requirements of ISO 13485, FDA 21 CFR Part 820, and the European CE IVDR.

ISO 13485 (Medical devices — Quality management systems): This standard demands a process-based approach to quality. For our LSR Injection Molding cell, this translates to rigorous process validation (IQ/OQ/PQ). The intelligence of the Arburg Selogica controller is paramount here. It allows us to not only define but also lock down and monitor hundreds of process parameters—from injection speed profiles and holding pressures to mold temperatures and cure times. Every cycle's data is logged, providing an unbroken chain of evidence that every part was produced within the validated window. This data is fundamental for risk management, allowing us to identify potential process drifts long before they result in non-conforming parts.

FDA 21 CFR Part 820 (Quality System Regulation): The FDA's QSR places heavy emphasis on Production and Process Controls (P&PC). Our core advantage—achieving net-shape parts directly from the mold—is a direct answer to these requirements. By eliminating secondary operations like manual or cryogenic deflashing, we remove significant sources of process variability and potential contamination. Competitors relying on such post-processing steps must validate them separately, introducing labor, cost, and risk. Our single-step process is inherently more controllable and validatable. The superior repeatability of the Arburg Allrounder H 600T's clamping unit, which maintains a parting line seal under 0.005 mm, ensures that the validated process remains stable from the first shot to the millionth. This stability is the bedrock of a compliant P&PC subsystem.

CE IVDR (In Vitro Diagnostic Regulation): The IVDR, which replaced the previous IVDD, imposes stricter requirements on clinical evidence and post-market surveillance for diagnostic devices. For component manufacturers, this means providing customers with unparalleled confidence in part quality and consistency. A key concern in POCT devices is birefringence—stress-induced variations in a material's refractive index. For optical components, this can scatter light and corrupt sensor readings, leading to a false diagnostic result. Our ability to fine-tune injection profiles with the Selogica controller ensures a gentle, complete mold fill that minimizes shear and thermal stresses. This prevents the formation of birefringence in the optical windows of the POCT cartridge, ensuring the final device performs as intended. By controlling these subtle material properties at the molding stage, we help our clients meet the rigorous performance and safety demands of the IVDR.

Core Process & Equipment Parameters

The synergy between material properties, machine capabilities, and process control is what defines this manufacturing solution. The following table outlines the critical parameters that enable us to deliver on the promise of flash-free, optically pure, and dimensionally precise POCT components.

Cost & Volume Dynamics: The Economics of Net-Shape Molding

The decision to invest in a high-precision manufacturing cell like the Arburg Allrounder H 600T for LSR molding is driven by a Total Cost of Ownership (TCO) calculation, not just the per-part price. This is especially true for production volumes scaling from 10,000 to over 1,000,000 units, the typical lifecycle for a successful POCT device.

At lower volumes (sub-10,000 units), the high upfront cost of the precision, cold-runner LSR mold can be prohibitive. However, as production scales, the economics invert dramatically. The core of our factory advantage lies in our mastery of net-shape molding. Effectively processing a low-viscosity material like LR 3003/50 is a game of millimeters and milliseconds. The Arburg Allrounder H 600T's robust and exceptionally repeatable clamping unit is the cornerstone of this capability. It guarantees that the parting line seal is maintained with a gap of less than 0.005 mm, cycle after cycle. This is not a theoretical specification; it is a production reality that directly prevents flash.

This single capability has a cascading effect on TCO. By eliminating flash, we eliminate the need for secondary deflashing operations. These operations, whether manual, cryogenic, or mechanical, are a significant cost driver for our competitors. They introduce labor costs, increase cycle time, and, most critically, create a new potential failure point. Manual deflashing is inconsistent and risks damaging the part. Cryogenic deflashing can induce thermal stress. Both add a contamination risk from handling and the environment—a catastrophic failure for a part destined for an ISO 13485 environment. Our process delivers parts that are ready for automated assembly directly from the mold. This translates to higher yield, lower labor costs, and a drastically reduced risk of quality escapes.

Furthermore, the Selogica controller's advanced diagnostics are not just for initial setup; they are a tool for ongoing optimization. We can fine-tune injection profiles to ensure the mold cavity fills completely without trapping air or inducing stress, which is critical for the optical clarity of sensor windows. This prevents birefringence and ensures the diagnostic accuracy of the final device. For a production run of 1,000,000+ units, even a 1% improvement in yield translates to 10,000 fewer scrapped parts, saving significant material and machine time. The stability and predictability of the process de-risk the entire supply chain for our clients, ensuring a consistent flow of validated components to meet market demand. This is the true economic value of a process built on precision and control.

Conclusion: Your Partner for Mission-Critical POCT Components

The development of advanced Point-of-Care Testing devices demands a manufacturing partner who operates at the same level of technical rigor as your own engineering team. At MechanoFab, we have engineered a specific, validated, and scalable solution for producing the most challenging LSR components. By combining the unique properties of Wacker ELASTOSIL LR 3003/50 with the uncompromising precision of the Arburg Allrounder H 600T and our deep process expertise, we deliver net-shape, optically pure, and fully compliant parts directly from the mold. We eliminate the risks and hidden costs of secondary operations, providing a robust manufacturing backbone for your most critical diagnostic products.